Annevirginie Eggimann Net Worth & Insider Trades

Annevirginie Eggimann - Chief Regulatory Officer, Bluebird Bio, Inc

As of July 14, 2022

What is Annevirginie Eggimann's Net Worth?

The current estimated net worth of Bluebird Bio, Inc's Chief Regulatory Officer, Annevirginie Eggimann, is estimated to be about $212.13K . Annevirginie Eggimann owns about 42,252 units of Bluebird Bio, Inc common stock. In the last 6 months at Bluebird Bio, Inc, Annevirginie Eggimann has sold an estimated value of $6.72K worth.

What is Annevirginie Eggimann's Past Insider Trading?

Annevirginie Eggimann's largest sale order was 1,358 units , worth over $6.72K on July 14, 2022. In total, Annevirginie Eggimann has made about 2 transactions over 6 months of their time at Bluebird Bio, Inc. Annevirginie Eggimann usually trades in February and July, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AnneVirginie Eggimann

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Annevirginie Eggimann's' Mailing Address?

  • Mailing address is C/o Codiak Biosciences, Inc. 35 Cambridgepark Drive, Suite 500 Cambridge MA 02140 MA

What are Bluebird Bio, Inc's Past Insider Trades?

Bluebird Bio, Inc's most recent insider trade came on September 6, 2023 by Thomas Klima who sold 922 units worth $3.49K . In the last 10 years, insiders at Bluebird Bio, Inc have sold an estimated value of $305.12M and bought an estimated value of $20.38M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are David Davidson, Chief Medical Officer,  Philip Gregory, Chief Scientific Officer,  and Jeffrey Walsh, Chief Strategy Officer .

bluebird bio, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...